rs201049092
Variant summary
Our verdict is Pathogenic. The variant received 13 ACMG points: 13P and 0B. PP1PP3PM2_SupportingPS3_ModeratePM3_StrongPP4_Strong
This summary comes from the ClinGen Evidence Repository: The NM_003494.4: c.1852G>A variant in DYSF, which is also known as NM_001130987.2: c.1906G>A p.(Gly636Arg), is a missense variant predicted to cause substitution of glycine by arginine at amino acid 618 (p.Gly618Arg). This variant has been detected in at least 7 unrelated individuals with LGMD2B. Of those individuals, at least 1 was compound heterozygous for the variant and a pathogenic or likely pathogenic variant (c.2811-2A>C, 1.0 pt, PMID:36983702). In addition, three unrelated individuals were homozygous for the variant (1.0 pt, PMID:26088049, 18853459, 32400077) (PM3_Strong). At least one patient with this variant displayed progressive weakness and reduced dysferlin protein expression, which is highly specific for DYSF-related LGMD (PP4_Strong, PMID:36983702). The variant was also reported to co-segregate with the disease in one affected family member (PP1; PMID:12471055). The highest population minor allele frequency in gnomAD v2.1.1 is 0.00004 (1/21646 alleles) in the European (Finnish) population, which is less than the ClinGen LGMD VCEP threshold (≤0.0001) for PM2_Supporting, meeting this criterion (PM2_Supporting). Immunofluorescence and 2-A assays of dysferlin membrane localization in HEK293T cells showed the Gly636Arg protein did not reach the cell membrane, indicating an impact on protein function (PMID:35028538) (PS3_Moderate). The computational predictor REVEL gives a score of 0.93, which exceeds the VCEP threshold of ≥0.70, evidence that correlates with impact to DYSF function (PP3). Another nucleotide change resulting in the same amino acid change, c.1852G>C p.(Gly618Arg), has been reported in association with LGMD (PMID:30564623) and classified as pathogenic by the LGMD VCEP. In summary, this variant meets the criteria to be classified as Pathogenic for autosomal recessive limb girdle muscular dystrophy based on the ACMG/AMP criteria applied, as specified by the ClinGen LGMD VCEP (LGMD VCEP specifications version 1.0.0; 01/08/2025): PP4_Strong, PM3_Strong, PM2_Supporting, PP3, PP1, PS3_Moderate. LINK:https://erepo.genome.network/evrepo/ui/classification/CA241938/MONDO:0015152/180
Frequency
Consequence
NM_001130987.2 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal recessive limb-girdle muscular dystrophyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- neuromuscular disease caused by qualitative or quantitative defects of dysferlinInheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health
- autosomal recessive limb-girdle muscular dystrophy type 2BInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
- distal myopathy with anterior tibial onsetInheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- congenital myopathy, Paradas typeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Miyoshi myopathyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 13 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001130987.2. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| DYSF | MANE Select | c.1906G>A | p.Gly636Arg | missense | Exon 20 of 56 | NP_001124459.1 | O75923-13 | ||
| DYSF | MANE Plus Clinical | c.1852G>A | p.Gly618Arg | missense | Exon 20 of 55 | NP_003485.1 | O75923-1 | ||
| DYSF | c.1903G>A | p.Gly635Arg | missense | Exon 20 of 56 | NP_001124453.1 | O75923-7 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| DYSF | TSL:1 MANE Select | c.1906G>A | p.Gly636Arg | missense | Exon 20 of 56 | ENSP00000386881.3 | O75923-13 | ||
| DYSF | TSL:1 MANE Plus Clinical | c.1852G>A | p.Gly618Arg | missense | Exon 20 of 55 | ENSP00000258104.3 | O75923-1 | ||
| DYSF | TSL:1 | c.1903G>A | p.Gly635Arg | missense | Exon 20 of 56 | ENSP00000386547.3 | O75923-7 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD2 exomes AF: 0.00000795 AC: 2AN: 251442 AF XY: 0.00000736 show subpopulations
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1461840Hom.: 0 Cov.: 35 AF XY: 0.00000688 AC XY: 5AN XY: 727220 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 33
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at